112 related articles for article (PubMed ID: 8905213)
1. Potential role of lipids in the progression of diabetic nephropathy.
Krämer-Guth A; Quaschning T; Greiber S; Wanner C
Clin Nephrol; 1996 Oct; 46(4):262-5. PubMed ID: 8905213
[TBL] [Abstract][Full Text] [Related]
2. Management of hypercholesterolaemia in the patient with diabetes.
Packard C; Olsson AG
Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
4. [Dyslipidemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy].
Martínez-Castelao A; Ramos R; González MT; Castiñeiras MJ
Nefrologia; 2002; 22 Suppl 1():51-8. PubMed ID: 11987671
[TBL] [Abstract][Full Text] [Related]
5. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
Chapman MJ; Guérin M; Bruckert E
Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
[TBL] [Abstract][Full Text] [Related]
6. [Nephropathy in non-insulin-dependent (type-2) diabetes mellitus].
Nagy J; Wittmann I
Orv Hetil; 2000 Mar; 141(12):609-14. PubMed ID: 10769544
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic treatment of type 2 diabetic dyslipidemia.
Moon YS; Kashyap ML
Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
[TBL] [Abstract][Full Text] [Related]
8. The renal hemodynamic basis of diabetic nephropathy.
O'Bryan GT; Hostetter TH
Semin Nephrol; 1997 Mar; 17(2):93-100. PubMed ID: 9148381
[TBL] [Abstract][Full Text] [Related]
9. Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies.
Bonnet F; Cooper ME
Diabetes Metab; 2000 Sep; 26(4):254-64. PubMed ID: 11011217
[TBL] [Abstract][Full Text] [Related]
10. Minimally oxidised LDL as estimated by a new method increase in plasma of type 2 diabetic patients with atherosclerosis or nephropathy.
Picard S; Talussot C; Serusclat A; Ambrosio N; Berthezène F
Diabetes Metab; 1996 Feb; 22(1):25-30. PubMed ID: 8697292
[TBL] [Abstract][Full Text] [Related]
11. [Genetic predisposition in multiple metabolic syndrome. Part 3. Metabolism of lipids, lipoproteins and apolipoproteins].
Sobra J; Ceska R
Cas Lek Cesk; 1999 Mar; 138(5):136-41. PubMed ID: 10376396
[TBL] [Abstract][Full Text] [Related]
12. [Lipid disorders in non-insulin dependent diabetes--principles of treatment].
Idzior-Waluś B
Przegl Lek; 1996; 53(9):653-9. PubMed ID: 8992531
[TBL] [Abstract][Full Text] [Related]
13. Effect of LDL cholesterol and treatment with losartan on end-stage renal disease in the RENAAL study.
Tershakovec AM; Keane WF; Zhang Z; Lyle PA; Appel GB; McGill JB; Parving HH; Cooper ME; Shahinfar S; Brenner BM
Diabetes Care; 2008 Mar; 31(3):445-7. PubMed ID: 18070995
[TBL] [Abstract][Full Text] [Related]
14. Optimizing antihypertensive therapy in patients with diabetic nephropathy.
Ritz E; Rychlík I; Miltenberger-Miltenyi G
J Hypertens Suppl; 1998 Sep; 16(7):S17-22. PubMed ID: 9855027
[TBL] [Abstract][Full Text] [Related]
15. Relation of lipid abnormalities to progression of renal damage in essential hypertension, insulin-dependent and non insulin-dependent diabetes mellitus.
Walker WG
Miner Electrolyte Metab; 1993; 19(3):137-43. PubMed ID: 8232100
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between platelet hyperactivation and dyslipoproteinemia in diabetic nephropathy].
Tóth L; Szénási P; Varsányi-Nagy M; Szilvási I; Vörös P; Romics L; Kammerer L
Orv Hetil; 1992 Apr; 133(17):1037-40. PubMed ID: 1579341
[TBL] [Abstract][Full Text] [Related]
17. Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients.
Seyoum B; Abdulkadir J; Berhanu P; Feleke Y; Mengistu Z; Worku Y; Ayana G
Ethiop Med J; 2003 Jan; 41(1):1-8. PubMed ID: 12764995
[TBL] [Abstract][Full Text] [Related]
18. Lipids in type 2 diabetes.
Laakso M
Semin Vasc Med; 2002 Feb; 2(1):59-66. PubMed ID: 16222596
[TBL] [Abstract][Full Text] [Related]
19. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
[TBL] [Abstract][Full Text] [Related]
20. Update on diabetic nephropathy in NIDDM.
Dere WH; Groggel GC
Geriatrics; 1990 Jul; 45(7):48-52, 55-6. PubMed ID: 2194907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
